Inizio Engage, formerly Ashfield Engage, is a global strategic, commercial and creative engagement partner focused on the healthcare sector. Leveraging a unique blend of consulting, creative development, and activation expertise combined with cutting‑edge technology, the firm designs and delivers customized solutions that drive sustainable change. With a network of over 7,000 specialists across more than 20 countries, Inizio Engage blends global reach with local insight to help clients rethink conventional approaches, empower patients, and improve treatment outcomes worldwide. As part of Inizio, the leading commercialization partner for health and life sciences, it simplifies complex challenges, unlocks value, and facilitates seamless collaboration at every critical stage, delivering personalized engagement that translates into real‑world impact.
Inizio Engage is partnering with a leading pharmaceutical client to recruit a Key Account Manager for haem-oncology, covering the North East England and North Cumbria territory. This is a standout opportunity for a driven and strategic sales professional to join a high-performing team with a market-leading oncology product and a robust pipeline.
Inizio Engage, formerly Ashfield Engage, is a global strategic, commercial and creative engagement partner focused on the healthcare sector. Leveraging a unique blend of consulting, creative development, and activation expertise combined with cutting‑edge technology, the firm designs and delivers customized solutions that drive sustainable change. With a network of over 7,000 specialists across more than 20 countries, Inizio Engage blends global reach with local insight to help clients rethink conventional approaches, empower patients, and improve treatment outcomes worldwide. As part of Inizio, the leading commercialization partner for health and life sciences, it simplifies complex challenges, unlocks value, and facilitates seamless collaboration at every critical stage, delivering personalized engagement that translates into real‑world impact.